Program | Posters

16:00-17:20, Friday, April 20, 2012
Basic and Clinical Studies in Surgical Infection

Moderators
Session 1: Microbiology, Biochemistry and Antibiotic Use. Matthew Rosengart, M.D., Gautam Bandyopadhyay, Ph.D., Kelly Hogan, Pharm.D.
Session 2: Surgical and Other Therapies. Greg Beilman, M.D., Samir Awad, M.D., Jose Prince, M.D.
Session 3: Surgical Site and Skin/Soft Tissue Infections. Marc Jeschke, MD, PhD and Lewis Kaplan, MD
Session 4: Other Infections. Phil Barie, M.D, Heather Evans, M.D., Alicia Mohr, M.D.
Session 5: Outcome and Risk Factor Analyses. Lillian Kao, M.D., Thomas Z. Hayward, III, M.D., Sandra Swoboda, R.N., M.S.

	Session 1: Microbiology, Biochemistry and Antibiotic Use | Back to Top
P1	Changes of Intestinal Microbiota in a Murine Model of Metastatic Breast Cancer. Valeriy Poroyko, Fred Kohlhapp, Alex Rodriguez, Alexander Ulanov, John Alverdy, Donald Liu, and José Guevara-Patiño. The University of Chicago
P2	Fascia Triggers Bacterial Virulence and May Play an Important Role in the Pathogenesis of Soft Tissue Infection After Muscle Injury. Moses Kim, Olga Zaborina, and John Alverdy. The University of Chicago
P3	Purification of the P-Glycoprotein (Pgp)-Inducing Component of Breast Milk. Elizabeth Pontarelli, Ashanti Franklin, Anatoly Grishin, and Henri Ford, Children's Hospital Los Angeles
P4	Dynamic Knowledge Representation of Host-Microbe Dynamics in Surgical Site infection (SSI) Using an Agent-Based Model. Vissagan Gopalakrishnan, Moses Kim, John Alverdy, and Gary An. The Johns Hopkins University
P5	Pharmacokinetics and Pulmonary Disposition of Tedizolid and Linezolid in Three Murine Models. Rebecca Keel, Jared Crandon, and David Nicolau. Hartford Hospital
P6	An Evaluation of the Absorption, Metabolism, and Excretion of Orally Administered [14C]-TR-701 FA in Healthy Subjects. H. Dreskin, T. Boyea, S. Flanagan, J. Barker, E. Fang, and Philippe Prokocimer. Trius Therapeutics, Inc.
P7	Pharmacokinetic and Pharmacodynamic Evaluation of Doripenem in Critically Ill Trauma Patients with Sepsis. Alissa Lockwood, Aryan Rahbar, Prasad Abraham, John Patka, Karen Curzio, Marina Rabinovich, Katleen Chester, Vanthida Huang, Brian Williams, Mitchell Chaar, Bryan Morse, Jeffrey Salomone, Jill Butterfield, and Thomas Lodise. Parkland Health and Hospital System
P8	Improved Pharmacokinetics of the Novel Oxazolidinone Antibiotic Tedizolid Phosphate Compared to Linezolid in Healthy Subjects. K. Munoz, S. Flanagan, P. Bien, and Philippe Prokocimer, Trius Therapeutics, Inc.
P9	Pulmonary Disposition of Tedizolid Following Once-Daily Oral 200 mg Tedizolid Phosphate in Healthy Adult Volunteers. S. Housman, J. Pope, J. Russomanno, E. Salerno, E. Shore, J. Kuti, and David Nicolau, Hartford Hospital
P10	Epidemiology and Antimicrobial Susceptibility of Pathogens Isolated from Infections of the Gallbladder-SMART 2002-2011. Robert Badal, Samuel Bouchillon, Aaron Johnson, Meredith Hackel, and Daryl Hoban. International Health Management Associates, Inc.
P11	Trauma after Transplant: Hold The Antibiotics. Jeffrey Tessier, Maxwell Sirkin, Luke Wolfe, and Therese Duane. Virginia Commonwealth University
P12	Antimicrobial Activity of the New Cephalosporin Ceftaroline Tested Against Bacterial Isolates from Surgical Skin and Skin Structure Infections in USA Medical Centers (2008-2011). Helio Sader, Donald Biek, Ian Critchley, Robert Flamm, and Ronald Jones, JMI Laboratories
P13	Is Extended Antibiotic Prophylaxis Necessary following Penetrating Trauma to the Thoracolumbar Spine with Concomitant Intraperitoneal Injuries?. Latha Pasupuleti, Ziad Sifri, and Alicia Mohr. University of Medicine and Dentistry of New Jersey-New Jersey Medical School
P14	Comparative Potency of Oxazolidinones Tedizolid (TR-700) and Linezolid Against Target Gram-Positive Pathogens in the United States from 2009-2010. C. Pillar, D. Sahm, and Ken Baritzal. Eurofins Medinet
	Session 2: Surgical and Other Therapies | Back to Top
P15	Appendicitis in Children with Cognitive Deficits. Elizabeth Pontarelli, Lauren Nosanov, Irene Ma, and James Pierce, Children's Hospital Los Angeles
P16	Protocolized Treatment of Appendicitis Leads to Decreased Cost Without increased infectious Complications. Shauna Levy, Elizabeth Johnson, Karen Williams, Meredith Wells, Kimberlee Taylor, Lillian Kao, Galit Holzmann-Pazgal, Kevin Lally, and KuoJen Tsao, University of Texas Medical School at Houston
P17	Fluid Resuscitation Using Enteral Route is a Safe And Effective Alternative to Parenteral Resuscitation. Saloni Raj, Kavita Baghel, Abhijit Chandra, and Rajeshwar Srivastava, CSM Medical University
P18	Regional Anesthesia Administered by a Multi-Disciplinary Pain Service Reduces Colorectal Surgical Infections. Peter Kim, Denise Sullivan, Lathan McCall, and Mindaugas Pranevicius. Albert Einstein College of Medicine
P19	Transumbilical Laparoscopically-Assisted Appendectomy (TULAA): A Cost-Effective Procedure for Appendicitis in Children. Jason Snyder, Alexandra Thomas, Lauren Keibel, Mikael Petrosyan, Evan Nadler, Randall Burd, and Faisal Qureshi. Children's National Medical Center
P20	Severe and Fulminant Clostridium difficile Colitis and the Timing of Surgical intervention. A Systematic Review of the Literature. Noubar Kevorkian, Chad Rennie, Hua Wang, Haidi Zhang, Armand Asarian, and Peter Pappas. The Brooklyn Hospital Center
P21	Emergent vs. Elective Cholecystectomy: Conversion Rates and Outcomes. Kathleen To, Jill Cherry-Bukowiec, Michael Englesbe, Cai Shijie, Michael Terjimanian, and Lena Napolitano. University of Michigan
P22	Alcohol Abuse Increased Mortality on Patients Undergoing Elective Colectomy. Yen-Hong Kuo, Yen-Liang Kuo, Nasim Ahmed, and John Davis. Jersey Shore University Medical Center
P23	Impact of Timing of Laparotomy on Outcome in Blunt Colo-Rectal Injury. Nasim Ahmed, Yen-Hong Kuo PhD, and John Davis. Jersey Shore University Medical Center
P24	Surgical Treatment of Typhoid Perforation in Children. John Lawrence. University of Vermont
	Session 3: Surgical Site and Skin/Soft Tissue Infections | Back to Top
P25	Institutional Observations of Bacterial Colonization of Operating Room Surfaces and Personnel Attire. Heather Van Sweringen, Katherine Van Oss, J. Wesley Alexander, and Michael Edwards. University of Cincinnati
P26	Surgical Site infection (SSI) in Breast Cancer Patients and its Impact on Long-Term Survival-A Retrospective Study from a New York City Community Hospital. Hua Wang, Awinder Singh, Aleem Surani, Larry Griffith, Alan Go, Armand Asarian, and Peter Pappas. The Brooklyn Hospital Center
P27	The morbidity of a Wound: Defining Surgical Site Infection (SSI) in Colorectal Surgery. Traci Hedrick, Robert Sawyer, and Charles Friel. University of Virginia
P28	Staphylococcus aureus Infection Rates and Risk Factors Across Seven Inpatient Surgical Subgroups In the United States. Holly Yu, Jack Mardekian, Gordon Siu, Edward Zito, and Douglas Girgenti. Pfizer, Inc.
P29	Surgical Site Infection Rates are Similar for Laparoscopic-Assisted and Open Colorectal Procedures. Alexander Antoniou, Phillip Fleshner, and Shirin Towfigh, Tufts University
P30	Surgical Site Infection (SSI) in Laparoscopic Ventral Hernia Repair (LVHR). Stacey Carter, Samir Awad, Marissa Clapp, Stephanie Hicks, Andres Avellaneda, Anuranda Subramanian, and Mike Liang. Baylor College of Medicine
P31	Microbiology of Surgical Site Infections (SSI) in Patients Undergoing Stoma Reversal. Jennifer Moffett, Andres Avellaneda, Mike Liang, Anuradha Subramanian, and Samir Awad. Baylor College of Medicine
P32	Surgical Site Infection in Colorectal Cancer Patients and its Impact on Survival-A Retrospective Study from a New York City Community Hospital. Awinder Singh, Hua Wang, Aleem Surani, Larry Griffith, Alan Go, Armand Asarian, and Peter Pappas. The Brooklyn Hospital Center
P33	Anatomic Variation in the Incidence of Monomicrobial Infection in Necrotizing Soft Tissue Infection of the Extremities. Laurie Punch, Mansoor Khan, Lynn Stansbury, Thomas Scalea, and Sharon Henry, University of Maryland, R Adams Cowley Shock Trauma Center
P34	Microbiological Efficacy of Tedizolid Phosphate in Patients with Complicated Skin and Skin Structure Infections. P. Bien, C. De Anda, and Philippe Prokocimer. Trius Therapeutics, Inc.
P35	Practicing Staged Amputations in Diabetics: Is it Time for Revision?. Omar Metwalli, Uma Phatak, Debbie Lew, Richard Escamilla, and Lillian Kao. University of Texas-Houston
P36	Can Polytetrafluoroethylene (PTFE) Remnants Be Left After Removal of Infected Grafts?. Ian Gordon, Karen Resnick, Russell Williams, and Samuel Eric Wilson. University of California-Irvine
P37	Surgical Exploration in Patients with Suspected Necrotizing Soft Tissue Infection. Uma Phatak, Debbie Lew, Richard Escamilla, and Lillian Kao. University of Texas-Houston
P38	Acute Bacterial Skin and Skin Structure Infection (ABSSSI) Dose-Ranging Phase 2 Tedizolid Phosphate (TR-701) Study: Assessment of Efficacy with New FDA Guidance. C. De Anda, A. Das, E. Fang, and Philippe Prokocimer, Trius Therapeutics, Inc.
P39	Safety Profile of Oral Tedizolid Phosphate 200, 300, or 400 mg Once Daily in an Acute Complicated Skin and Skin Structure Infection Phase 2 Study. C. De Anda, P. Bien, and Philippe Prokocimer, Trius Therapeutics, Inc.
P40	Trend and Outcome of Necrotizing Fasciitis. Nasim Ahmed, Yen-Hong Kuo, Yen-Liang Kuo, and John Davis. Jersey Shore University Medical Center
P41	Correlation between Digital Planimetry and a Manual Method in the Measurement of Lesion Size in a Phase 3 Acute Bacterial Skin and Skin Structure Infection (ABSSSI) Study. P. Bien, C. De Anda, E. Fang, and Philippe Prokocimer. Trius Therapeutics, Inc.
	Session 4: Other Infections | Back to Top
P42	Variations in Isolated Organisms of Blood Stream Infections Over Time. Christopher Guidry, Laura Rosenberger, Tjasa Hranjec, Stephen Davies, Matthew McLeod, Amani Politano, Lin Riccio, and Robert Sawyer. University of Virginia
P43	Ventilator-Associated Pneumonia (VAP) in the Elderly Trauma Patient: There's No Place lLke Home. Laura Moore, Edmundo Dipasupil, John Holcomb, and Rosemary Kozar. The University of Texas-Houston
P44	10-Year Review of Isolated Severe Traumatic Brain Injury (TBI); What is the Impact of Very Early Tracheostomy?. Anastasia Kunac, Ziad Sifri, Alicia Mohr, Robert Lavery, and David Livingston. University of Medicine and Dentistry of New Jersey-New Jersey Medical School
P45	In-hospital Infections Following Traumatic Splenic Injury: Does Mode of Management Matter?. Matthew McLeod, Robert Sawyer, Laura Rosenberger, Tjasa Hranjec, and Amani Politano. University of Virginia
P46	Association of Lewis Blood-Group Phenotype with Recurrent Urinary Tract Infection in Women Transplant Recipients. David Conti, Nicole Siparsky, Jeannie Colaneri, Rachel Dellehunt, and Michael Gallichio, Albany Medical College
P47	Aspergillus Infections in Transplant and Non-Transplant Surgical Patients. Stephen Davies, Christopher Guidry, Amani Politano, Laura Rosenberger, Matthew McLeod, Tjasa Hranjec, and Robert Sawyer. University of Virginia
P48	Changes in the Postoperative Infectious Pathogens between 2001 and 2006. John Davis, Yen-Hong Kuo PhD, Nasim Ahmed, and Yen Liang Kuo. Jersey Shore University Medical Center
P49	Trials and Tribulations; the Expedited Development of an Invasive Fungal Infection (IFI) Clinical Practice Guideline (CPG). Carlos Rodriguez, James Dunne, David Tribble, Justin Wells, Mark Fleming, Tyler Warkentien, Amy Weintrob, and Debra Malone. Walter Reed National Military Medical Center
	Session 5: Outcome and Risk Factor Analyses | Back to Top
P50	What is the Prognostic Value of Leukocytosis in Surgical Infections?. Tjasa Hranjec, Laura Rosenberger, Amani Politano, Lin Riccio, Matthew McLeod, Christopher Guidry, Stephen Davies, and Robert Sawyer. University of Virginia
P51	Hepcidin and Anemia in Surgical Critical Care. Jill Cherry-Bukowiec, Krishnan Raghavendran, Kristin Brierley, Pauline Park, and Lena Napolitano. University of Michigan
P52	The Association Between Inflammatory and Hemodynamic Response in Geriatric Trauma Patients. Thomas Herron, Sean Monaghan, Stefan Gravenstein, William Cioffi, Alfred Ayala, and Daithi Heffernan, Brown University
P53	Complex Vital Sign Characteristics Predict ICU-Acquired Infections. Lin Riccio, Amani Politano, Doug Lake, Laura Rosenberger, Randall Moorman, Robert Sawyer, and J. Forrest Calland. University of Virginia
P54	Cytokine Levels in Patients with and without Fungal Infections. Amani Politano, Laura Rosenberger, Matthew McLeod, Tjasa Hranjec, Lesle Dossett, Addison May, and Robert Sawyer. University of Virginia
P55	Why is the Post-Burn Outcome of Elderly Patients So Poor? Insights from Inflammatory Cytokine and Metabolic Hormone Profiling. Marc Jeschke, Alison Cheung, Yaeko Hiyama, Rachael Harrison, and Alexandra Smith. Sunnybrook Health Sciences Center
P56	Evaluation of Neutrophil CD64 as a Marker of Sepsis in Burn Patients. Fernando Rivera, Agnes Burris, Ming-Mei Liu, and Joseph Minei, University of Texas= Southwestern
P57	Fungal Wound Invasion is Associated with Increased Mortality in Pediatric Burn Patients. Noe Rodriguez, Celeste Finnerty, Brendan Calhoun, Hal Hawkins, and David Herndon, University of Texas Medical Branch/Shriners Hospitals for Children
P58	Evaluation of Nasal Methicillin-Resistant Staphylococcus aureus (MRSA) Polymerase Chain Reaction (PCR) as a Screening Tool in Burn Center Patients. Linwood Haith, Christine Young, Bruce Ackerman, Cynthia Reigart, Megan Stair-Buchmann, Mary Patton, Robert Guilday, Stephen Nelson, and William Ravreby, The Nathan Speare Regional Burn Treatment Center, Crozer-Chester Medical Center